EssilorLuxottica 1st Half Earnings Rose, Backs Mid-Term Growth Targets
By Maitane Sardon
EssilorLuxottica on Tuesday said sales and earnings rose in the first half and backed its growth targets for 2026.
The Franco-Italian eyewear group made an adjusted operating profit of 2.35 billion euros ($2.60 billion) in the half year, rising 9% at constant currency from the same period last year.
The group's operating margin was 18.5%, and it made a net profit of EUR1.36 billion.
Revenue came in at EUR12.85 billion, an increase of 8% at constant exchange rates.
Second-quarter revenue growth was spread across all the business areas with the exception of sun retail in the U.S., which posted a negative performance on the back of softening market demand, EssilorLuxottica said.
Looking ahead, the company backed its target of mid-single-digit annual revenue growth from 2022 to 2026 at constant exchange rates and said it expects to achieve an adjusted operating profit as a percentage of revenue in the range of 19% to 20% by the end of 2026.
Write to Maitane Sardon at maitane.sardon@wsj.com
(END) Dow Jones Newswires
July 25, 2023 12:42 ET (16:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting